United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average (own scale)
Sector average
Sector average (own scale)
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Oncology Institute, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | 999.19% | 86.88% | 93.69% | 85.75% | 83.53% | 81.93% |
| Sector average | 22.99% | 73.17% | 65.88% | 68.36% | 41.61% | 44.34% |
| ROA | -35.93% | -13.27% | -32.57% | -65.25% | -134.99% | -289.82% |
| Gross Margin | 100% | 100% | 100% | 100% | 100% | 100% |
| Sector average | 45.84% | 46.72% | 46.7% | |||
| Net Margin | -12.06% | -3.96% | -9.9% | -19.69% | -41.59% | -91.86% |
| Total Assets | $164,656.00K | $199,418.53K | $232,186.89K | $274,644.28K | $310,848.91K | $331,485.86K |
| Sector average | $3,516,665.42K | $3,537,396.33K | $3,954,880.66K | |||
| Net Income | -$60,606.00K | -$24,149.08K | -$70,279.52K | -$165,344.97K | -$395,192.93K | -$930,797.40K |
| 45.37% |
| 44.33% |
| 43.24% |
| $4,602,556.36K |
| $5,424,035.31K |
| $6,260,073.84K |